Prevalence of Cognitive Impairment and Its Associated Factors in Elderly Patients under Chronic Hemodialysis Treatment
Publish place: Journal of Medicinal and Chemical Sciences، Vol: 4، Issue: 6
Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 225
This Paper With 14 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JMCH-4-6_013
تاریخ نمایه سازی: 8 آذر 1400
Abstract:
The present study was a cross-sectional investigation carried out on elderly patients under chronic hemodialysis who referred to Firoozabadi Hospital during ۲۰۱۹- ۲۰۲۰. The study population was ۸۰ patients ≥ ۶۰ years. The patients’ cognitive status was determined using MMSE and MOCA tools. The mean age of the candidate patients was ۷۱.۷۱ ± ۶.۲۸ years old. Cognitive function was assessed by MMSE and MoCA tests and the mean score of the MMSE test was ۲۰.۰۵ ± ۳.۵۰ with the highest score being ۲۶ and the lowest score being ۱۲. Based on the results, these patients were divided into three groups with normal cognitive function, mild cognitive impairment, and severe cognitive impairment. According to the results of the MMSE test, ۱۹ patients (۲۳.۷۵%) had a normal cognitive function and ۴۵ patients (۵۶.۲۵%) had impairment. In other words, the older patients, the lower level of education, the longer duration of hemodialysis, and the patients with a history of diabetes were more susceptible to cognitive impairment. Subsequently, there was a positive correlation between the levels of BUN, creatinine, uric acid, and PTH, which means that the higher level of these variables in patients was related to the higher risk of cognitive impairment. The findings of the present investigation revealed that the cognitive function and the studied variables including age, level of education, history of diabetes, hemodialysis duration, BUN, Creatinine, Uric Acid, PTH, Sodium, and Kt/V had a significant difference in patients undergoing hemodialysis.
Keywords:
Authors
Raheleh Alimoradzadeh
Firoozabadi Clinical Research Development Unit (FACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran
Hosna Ranjbar
Iran University of Medical Sciences, Tehran, Iran
Mohammad Amin Abbasi
Firoozabadi Clinical Research Development Unit (FACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran
Fatemeh Montazer
Firoozabadi Clinical Research Development Unit (FACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :